Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasiglucagon for severe hypoglycemia in children with T1DM
NCT03667053Phase 3Completed
- Sponsor
- Zealand Pharma
- Start
- Sep 2018
- Primary completion
- Jun 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of dasiglucagon in hypoglycemia, sponsored by Zealand Pharma. Started Sep 2018; status: completed.
02
Drugs
dasiglucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT03667053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03667053.